-
81
Baseline (derived) neutrophil-lymphocyte ratio associated with survival in gastroesophageal junction or gastric cancer treated with ICIs
Published 2025-01-01Subjects: “…immune checkpoint inhibitors…”
Get full text
Article -
82
Chemotherapy in synergy with innate immune agonists enhances T cell priming for checkpoint inhibitor treatment in pancreatic cancer
Published 2025-01-01Subjects: Get full text
Article -
83
Interdependence of coagulation with immunotherapy and BRAF/MEK inhibitor therapy: results from a prospective study
Published 2024-11-01Subjects: “…Immune checkpoint inhibitors…”
Get full text
Article -
84
The characteristics of the tumor immune microenvironment in colorectal cancer with different MSI status and current therapeutic strategies
Published 2025-01-01Subjects: Get full text
Article -
85
Subacute parkinsonism induced by immune checkpoint inhibitors
Published 2024-12-01Subjects: “…immune checkpoint inhibitor…”
Get full text
Article -
86
Exploring the role of metabolic pathways in TNBC immunotherapy: insights from single-cell and spatial transcriptomics
Published 2025-01-01Subjects: Get full text
Article -
87
Assessing hemorrhagic risks in combination therapy: implications of angiogenesis inhibitors and immune checkpoint inhibitors
Published 2025-02-01Subjects: “…immune checkpoint inhibitors…”
Get full text
Article -
88
DNA methylation and immune evasion in triple-negative breast cancer: challenges and therapeutic opportunities
Published 2025-02-01Subjects: Get full text
Article -
89
-
90
Hidradenitis suppurativa induced by ipilimumab and nivolumab: A rare association
Published 2025-03-01Subjects: Get full text
Article -
91
Editorial: Tertiary lymphoid structures (TLS) in the tumor immune microenvironment
Published 2025-01-01Subjects: Get full text
Article -
92
Pathological Complete Response to a Single Dose of Pembrolizumab‐Based Chemoimmunotherapy for Squamous Cell Carcinoma of the Lung: A Case Report
Published 2025-01-01Subjects: “…immune checkpoint inhibitors…”
Get full text
Article -
93
The effect of baseline versus early glucocorticoid use on immune checkpoint inhibitor efficacy in patients with advanced NSCLC
Published 2025-01-01Subjects: Get full text
Article -
94
-
95
High-dose ascorbic acid synergizes with anti-PD1 therapy in non-small cell lung cancer in vitro and in vivo models
Published 2025-01-01Subjects: Get full text
Article -
96
Case report: Multi-organ injuries induced by tislelizumab
Published 2025-02-01Subjects: Get full text
Article -
97
-
98
Catalysts of change: Immunotherapy's frontier in oral oncology
Published 2024-09-01Subjects: Get full text
Article -
99
Sinonasal small-cell carcinoma combined concurrently with small-cell lung carcinoma: case report and literature review
Published 2025-01-01Subjects: Get full text
Article -
100
The role of immunotherapy in the treatment of lip squamous cell carcinoma: A series of six cases and a review of the current literature
Published 2024-06-01Subjects: Get full text
Article